Lanka Hospitals Corp. Plc

  • Market Cap: Mid Cap
  • Industry: Hospital
  • ISIN: LK0318N00002
LKR
106.00
23.7 (28.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROE of 15.42%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 58.10

 
3

With ROE of 11.03%, it has a expensive valuation with a 1.46 Price to Book Value

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

LKR 24,275 Million (Mid Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.09%

stock-summary
Debt Equity

-0.64

stock-summary
Return on Equity

11.75%

stock-summary
Price to Book

1.61

Revenue and Profits:
Net Sales:
3,615 Million
(Quarterly Results - Sep 2025)
Net Profit:
415 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
37.66%
0%
37.66%
6 Months
34.18%
0%
34.18%
1 Year
-6.19%
0%
-6.19%
2 Years
-1.85%
0%
-1.85%
3 Years
96.66%
0%
96.66%
4 Years
135.56%
0%
135.56%
5 Years
178.95%
0%
178.95%

Lanka Hospitals Corp. Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.93%
EBIT Growth (5y)
25.53%
EBIT to Interest (avg)
58.10
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
0.93
Tax Ratio
24.43%
Dividend Payout Ratio
25.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
42.68%
ROE (avg)
15.42%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.46
EV to EBIT
4.38
EV to EBITDA
3.39
EV to Capital Employed
2.22
EV to Sales
0.89
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
50.59%
ROE (Latest)
11.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 1.25% vs 5.84% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -7.26% vs 31.90% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,615.40",
          "val2": "3,570.80",
          "chgp": "1.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "963.40",
          "val2": "925.30",
          "chgp": "4.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.70",
          "val2": "13.50",
          "chgp": "1.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "415.30",
          "val2": "447.80",
          "chgp": "-7.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "207.40%",
          "val2": "199.00%",
          "chgp": "0.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 9.92% vs 16.08% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -0.43% vs -58.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,650.10",
          "val2": "12,418.60",
          "chgp": "9.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,640.50",
          "val2": "3,058.20",
          "chgp": "19.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "57.90",
          "val2": "33.00",
          "chgp": "75.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,339.40",
          "val2": "1,345.20",
          "chgp": "-0.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "210.80%",
          "val2": "192.10%",
          "chgp": "1.87%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
3,615.40
3,570.80
1.25%
Operating Profit (PBDIT) excl Other Income
963.40
925.30
4.12%
Interest
13.70
13.50
1.48%
Exceptional Items
0.00
0.00
Consolidate Net Profit
415.30
447.80
-7.26%
Operating Profit Margin (Excl OI)
207.40%
199.00%
0.84%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 1.25% vs 5.84% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -7.26% vs 31.90% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
13,650.10
12,418.60
9.92%
Operating Profit (PBDIT) excl Other Income
3,640.50
3,058.20
19.04%
Interest
57.90
33.00
75.45%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1,339.40
1,345.20
-0.43%
Operating Profit Margin (Excl OI)
210.80%
192.10%
1.87%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 9.92% vs 16.08% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -0.43% vs -58.57% in Dec 2023

stock-summaryCompany CV
About Lanka Hospitals Corp. Plc stock-summary
stock-summary
Lanka Hospitals Corp. Plc
Hospital
The Lanka Hospitals Corporation PLC is a tertiary care hospital in Sri Lanka, which is engaged in providing healthcare solutions. The Company's principal activity is to provide healthcare and laboratory services. It specializes in a range of procedures from conventional to minimally invasive surgeries. The Company offers various medical services, including emergency services, heart center, renal care, hemato-oncology, fertility center, kidney care center, vaccinations, surgical department, radiology services, eye clinic, mother and baby care, dental clinic, physiotherapy, dermatology, gastroenterology and neurosciences, among others. The Company, through its diagnostic laboratory, Lanka Hospitals Diagnostics (LHD), offers a range of diagnostic facilities, including fields, such as hematology, histopathology, chemical pathology, microbiology, molecular diagnostics, cytogenetics and flow cytometry. The Company's subsidiary is Lanka Hospitals Diagnostics (Private) Limited.
Company Coordinates stock-summary
Company Details
No.578, Elvitigala Mawatha, Narahenpita, Colombo 05 COLOMBO None : 05
Registrar Details